CSBR
Champions Oncology Inc
Halal Rating :
Last Price
$9.93
Last updated:
Market Cap
-
7D Change
8.29%
1 Year Change
55.64%
Company Overview
Industries
Exchange
Next Earnings Date
Champions Oncology, Inc. is a technology-driven research organization that provides innovative oncology solutions and software. The company primarily offers preclinical and clinical research services, including patient-derived xenograft (PDX) models, biomarker research, and data analytics for cancer drug development.
The company's main revenue streams come from providing research services to pharmaceutical and biotechnology companies to assist in their drug development processes, particularly in oncology.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Oct. 31, 2024 | $13.49m | $12.76m | - | - | 0.00% | 0.00% |
| July 31, 2024 | $14.06m | $12.73m | - | - | 0.00% | 0.00% |
| April 30, 2024 | $14.0m | $14.27m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Champions Oncology Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.